Skip to content
AlternativeMed

Kava (Piper methysticum): Uses, Evidence and Safety

Kava root (Piper methysticum): rare but serious liver injury, bans in several countries, mixed trial results for anxiety, and sedative, alcohol and pregnancy cautions.

Content last updated . This page has not been medically reviewed.

Close-up of kava (piper methysticum): uses, evidence and safety

Safety first. Natural products can cause side effects and interact with medicines. Read herb safety and interactions before you use anything on this page.

Documented analytical data

Each group below is one study's measurement of the stated specimen or preparation. It is not a typical value for the species or product, varies between specimens, and says nothing about effects or safety. 6 values from 1 source.

Tang Y, Fields C. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Piper... (6 values)

Source: Tang Y, Fields C. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Piper methysticum (Kava). Molecules 2019;24:1245. DOI 10.3390/molecules24071245. Authors at the company that supplied the root and funded the study. Read 2026-10-22. Laboratory: Applied Food Sciences, Inc., Coralville, Iowa, USA (company also supplied the root and funded the study). Method: UHPLC-UV (239 nm, HSS T3 column), validated. Date: not reported in source (paper received 2019-03-02).

Measured values
Specimen or preparationAnalyteValueWhat it isSample size and scope
Piper methysticum kava root (raw material supplied by the company)desmethoxyyangonin (DMY)7.29 mg/g (as reported (mg per g of root powder; moisture not stated))(reported)15. single material, inter-day mean of 15 determinations (3 days x 5); SD 0.07
Piper methysticum kava root (raw material supplied by the company)dihydrokavain (DHK)14.74 mg/g (as reported (mg per g of root powder; moisture not stated))(reported)15. single material, inter-day mean of 15 determinations (3 days x 5); SD 0.15
Piper methysticum kava root (raw material supplied by the company)dihydromethysticin (DHM)11.02 mg/g (as reported (mg per g of root powder; moisture not stated))(reported)15. single material, inter-day mean of 15 determinations (3 days x 5); SD 0.11
Piper methysticum kava root (raw material supplied by the company)kavain25.3 mg/g (as reported (mg per g of root powder; moisture not stated))(reported)15. single material, inter-day mean of 15 determinations (3 days x 5); SD 0.59
Piper methysticum kava root (raw material supplied by the company)methysticin20.19 mg/g (as reported (mg per g of root powder; moisture not stated))(reported)15. single material, inter-day mean of 15 determinations (3 days x 5); SD 0.17
Piper methysticum kava root (raw material supplied by the company)yangonin18.62 mg/g (as reported (mg per g of root powder; moisture not stated))(reported)15. single material, inter-day mean of 15 determinations (3 days x 5); SD 0.16
HerbPiper methysticum

What is Kava good for?

What the body uses it for, and how strong the evidence is. A normal job in the body is not proof that extra supplements add benefit; each card says which.

Short-term anxiety relief

Preliminary or mixed

A Cochrane review of 11 trials (2003) found kava extract reduced anxiety scores more than placebo over 1 to 24 weeks; NCCIH says supplements may help but may need several weeks.

Supplements: Possible short-term effect in some trials; not shown for diagnosed generalised anxiety disorder.

Generalised anxiety disorder

Preliminary or mixed

A 16-week trial in 171 people with diagnosed generalised anxiety disorder found no significant difference from placebo. NCCIH says kava does not appear to help generalised anxiety disorder.

Supplements: No benefit shown in this trial.

Sleep and insomnia

Not enough evidence

MSK says no scientific evidence supports kava for insomnia.

Supplements: No good evidence of benefit in the sources read.

Animal cancer findings

Lab or animal research only

The FDA memo reports sufficient evidence in rodents for liver tumours from kava extract; MSK mentions a kava compound that stimulated melanoma cell growth in a mouse study. EMA noted carcinogenic potential in animals.

Supplements: No human benefit shown; a lab caution.

Connected topics

Open a group to see how each topic connects and how strong the evidence is.

Health goals (2)
  • Anxiety SupportPreliminary or mixed

    Kava is used for anxiety. A 2003 Cochrane review found a benefit over placebo, but a 2020 trial in diagnosed generalised anxiety disorder did not, so evidence is mixed and a serious liver warning applies.

  • Calm & RelaxationPreliminary or mixed

    Kava is drunk for its relaxing effect and used for anxiety. Trial results are mixed and liver injury is a serious warning.

Body systems (5)
  • Hepatic / Liver SystemDocumented risk

    Kava products have been linked to rare but serious or fatal liver injury, including liver failure needing transplant. Memorial Sloan Kettering says the liver risk outweighs any benefits.

  • Liver & DetoxDocumented risk

    Kava products have been linked to rare but serious or fatal liver injury, including liver failure needing transplant. Memorial Sloan Kettering says the liver risk outweighs any benefits.

  • Nervous SystemDocumented risk

    Kava can cause drowsiness and impaired reflexes, and adds to the effect of alcohol and sedatives such as benzodiazepines.

  • Integumentary SystemDocumented risk

    Long-term heavy use can cause kava dermopathy: dry, scaly skin.

  • Stress & MoodPreliminary or mixed

    Kava is used for anxiety. A 2003 Cochrane review found a benefit over placebo, but a 2020 trial in diagnosed generalised anxiety disorder did not, so evidence is mixed and a serious liver warning applies.

Body parts (3)
  • LiverDocumented risk

    Kava products have been linked to rare but serious or fatal liver injury, including liver failure needing transplant. Memorial Sloan Kettering says the liver risk outweighs any benefits.

  • Nervous SystemDocumented risk

    Kava can cause drowsiness and impaired reflexes, and adds to the effect of alcohol and sedatives such as benzodiazepines.

  • SkinDocumented risk

    Long-term heavy use can cause kava dermopathy (dry, scaly skin) and itchy or burning rashes.

Functional actions (1)
  • CalmingPreliminary or mixed

    Traditionally drunk for its relaxing effect; kavalactones are thought to relax muscle and have sedating effects. Human trial support for anxiety is mixed.

Root causes (1)
  • Kava should not be combined with alcohol, benzodiazepines or other sedatives, and may add to the liver effects of acetaminophen. Ask a pharmacist.

Biomarkers (2)
  • ALTDocumented risk

    Liver blood tests can be raised in kava users, and abnormal ALT was reported in some studies of heavy drinkers. A 2020 trial found more abnormal liver tests with kava than placebo.

  • ASTDocumented risk

    Liver blood tests can be raised in kava users, and abnormal AST was reported in some studies of heavy drinkers. A 2020 trial found more abnormal liver tests with kava than placebo.

Conditions & symptoms (4)
  • Hepatitis, ToxicDocumented risk

    Kava products have been linked to rare cases of liver injury (hepatitis), some serious or fatal.

  • Kava is among supplements with documented liver injury; causality was assessed with the RUCAM method in a 2019 case report.

  • Liver Failure, AcuteDocumented risk

    Case reports describe acute liver failure needing transplant after kava use; a WHO review quoted by the FDA counted 14 transplants and 7 deaths among 93 reports.

  • AnxietyPreliminary or mixed

    A 2003 Cochrane review found kava extract beat placebo for anxiety over 1 to 24 weeks; NCCIH says supplements may help but the liver risk is serious.

Documented risks and interactions (7)
  • Liver injury risk. Kava products have been linked to rare cases of liver injury, some serious or fatal, including liver failure needing a transplant. Memorial Sloan Kettering says the risk of liver damage outweighs any benefits.
  • Sedation and combining with alcohol or sedatives. Kava can make you drowsy and slow reactions. NCCIH and MSK advise against combining it with alcohol, benzodiazepines or other sedatives; do not drive afterwards.
  • Medicine interactions. MSK lists benzodiazepines and other sedatives, acetaminophen (more liver toxicity in lab studies) and medicines handled by CYP1A2 or CYP2E1, while calling overall interaction risk low. The FDA memo says kava may interact with many drugs and herbs.
  • Pregnancy and breastfeeding. NCCIH says kava may carry special risks in pregnancy and breastfeeding because of its pyrone compounds. The FDA memo notes inadequate studies on reproductive and developmental harm.
  • Skin effects (kava dermopathy) and other side effects. Long-term heavy use can cause dry, scaly skin (kava dermopathy), reddened eyes and temporary yellowing of skin, hair and nails. Headache, dizziness, digestive upset and itching or burning rashes are also listed.
  • Surgery and anaesthesia. MSK advises stopping kava before surgery because it may interact with anaesthetics and add to sedation.
  • Regulatory restrictions. The EU herbal committee found the benefit-risk balance unfavourable and decided no EU monograph can be set. The FDA memo lists withdrawals or bans in several countries, and calls kava an unapproved food additive in conventional foods.

Explore all 414 herbs

Safety first: liver injury, national restrictions and sedatives

Kava has been linked to rare cases of liver injury, some serious or fatal. NCCIH (part of NIH) says this in plain terms, and adds that some cases involved kava drinks made with water, not only products extracted with alcohol or acetone. [1] Memorial Sloan Kettering (MSK) goes further: it says the risk of liver damage outweighs any benefits. [2] Its warning signs are yellowing of the skin, eyes or nails, nausea and vomiting, and it says to contact a doctor right away if they appear. [2] A US FDA toxicology memo (2020) describes a World Health Organization review of 93 case reports of suspected kava liver harm, with 7 deaths and 14 liver transplants. [3] The same memo says the FDA warned consumers and doctors in 2002, and that kava has been withdrawn or banned in several countries. [3] The European Medicines Agency (EMA) committee for herbal medicines found the balance of benefit and risk unfavourable and decided that an EU herbal monograph cannot be established. [4] Kava should not be combined with alcohol or with sedating medicines. [1][2] Anyone with liver or kidney problems, who is pregnant or breastfeeding, who is taking medicines, or who has surgery planned should not use kava supplements without medical advice. See liver safety and supplements and supplements before surgery.

Overview

Kava is a drink or extract made from the root and rhizome (underground stem) of Piper methysticum G. Forst., a shrub in the pepper family (Piperaceae). [1][3] The FDA memo says it is native to Polynesia, Micronesia and Melanesia, and that the root is the part consumers ordinarily use. [3] NCCIH lists other names such as kava kava, awa and kawa. [1] The effects are linked to compounds called kavalactones. [2] This page covers kava root products: the traditional drink, powders, capsules and tablets, and extracts. Kava teas and tea-like drinks are signposted at kava, kratom and blue lotus teas. In the US, kava is sold as a dietary supplement, and in some other countries as a drug or herbal medicine. [1]

Traditional use (not proof of benefit)

Pacific Islanders have used kava drinks for thousands of years for ceremonies and for medicine, and kava bars now operate in many places, including US locations. [1] The FDA memo describes the traditional drink as macerated root mixed with cold water or coconut milk, drunk socially for its relaxing effect. [3] How long a plant has been drunk tells us about custom, not about whether it treats anxiety or is safe in a supplement. The findings below come from human trials and safety reports. For wider context see Kava in Specialty Topics.

What research shows

NCCIH says there has been a fair amount of human research on kava for anxiety, and little on other conditions. [1]
UseWhat the sources foundStrength of evidenceForm and population
Anxiety (short-term, mixed groups)A Cochrane review (2003) of 11 trials (645 people) found that kava extract reduced anxiety scores more than placebo in a pooled analysis of six trials, with mild and infrequent side effects over 1 to 24 weeks. The authors said more information on long-term safety was needed. [5]Promising but limited (old trials; the review pre-dates the safety concerns below)Kava extract; adults with anxiety
Diagnosed generalised anxiety disorderA 2020 trial in Australia (171 people, 16 weeks) found no significant difference from placebo. Memory problems and tremor were reported more often with kava, and liver blood-test abnormalities were more frequent, although no one met the criteria for herb-induced liver injury. [6] NCCIH says kava does not appear to help generalised anxiety disorder symptoms. [1]No good evidence of benefitAqueous (water-based) root extract tablets; adults
Anxiety, overallNCCIH: kava supplements may help anxiety but may need several weeks. [1] MSK: results are mixed. [2]MixedVaries by product
InsomniaMSK: no scientific evidence supports this use. [2]No good evidence of benefitNot applicable
Any other conditionNCCIH: not enough evidence to show whether kava helps any other condition. [1]Insufficient evidenceNot applicable
CancerMSK mentions one study linking kava drinking to low cancer rates, and a kava compound that stimulated melanoma cell growth in mice. [2] The FDA memo reports enough evidence in rodents of liver tumours from kava extract. [3]Lab and animal findings only; no human evidence of benefitAnimal and lab

Whether the 2003 Cochrane result still holds for today's products: Proper evidence not found in the sources we read (the later 2020 trial was negative for diagnosed generalised anxiety disorder).

Forms and why the form matters

Kava products differ in how they are made. The FDA memo says commercial products have mostly been ethanol, methanol or acetone extracts standardised to kavalactone content, while the traditional drink is made with water. [3] The WHO review quoted in that memo noted a higher rate of liver reports with organic-solvent extracts. [3] But NCCIH says some liver cases involved water-prepared drinks, so a water extract is not proven safe. [1] NCCIH lists possible contributing factors, none settled: unsuitable varieties or plant parts, alcohol, adulteration or contamination, genetic differences, and large amounts or long use. [1] A result seen with one product should not be assumed for another. How much to use is a decision for a clinician, not this page.

Safety in more detail

  • Liver: NCCIH reports rare serious or fatal liver injury. [1] MSK says risk is higher with prolonged use or with other botanicals, supplements or prescription medicines, and describes a case of acute liver failure needing a transplant after about two months of use without evidence of excess. [2] A 2019 case report describes liver failure and transplant in a woman after 52 days of a kava product at a standard dose; chemical testing found no contaminants. [7] The FDA memo adds that heavy kava drinkers often show raised liver blood tests. [3]
  • Common side effects: NCCIH lists digestive upset, headache and dizziness. [1] MSK adds sedation, impaired reflexes or judgement, visual disturbances, restlessness, tremor and a "hangover" effect. [2] Do not drive or use heavy machinery after kava. [2]
  • Skin: long-term heavy use can cause kava dermopathy (dry, scaly, flaky skin), reddened eyes and temporary yellowing of skin, hair and nails. [1][2]
  • Medicines: do not combine with benzodiazepines, other sedatives or alcohol, which can add to drowsiness. [1][2] MSK also warns about acetaminophen (paracetamol), where lab studies suggested more liver toxicity, and about medicines processed by liver enzymes such as CYP1A2 and CYP2E1, while calling the overall interaction risk low. [2] Ask a pharmacist. See sedatives, sleep medicines and alcohol.
  • Pregnancy: NCCIH says kava may carry special risks in pregnancy because of its pyrone compounds. [1] The FDA memo notes a lack of studies on reproductive and developmental harm. [3] MSK does not address pregnancy. [2] The sources we read give no reassurance, so avoid unless a doctor advises otherwise.
  • Breastfeeding: NCCIH says the same caution applies. [1] Other details: Proper evidence not found in the sources we read.
  • Children: Proper evidence not found in the sources we read.
  • Liver and kidney disease: MSK advises people with liver or kidney problems to avoid kava. [2]
  • Surgery: MSK advises stopping kava before surgery because it may interact with anaesthetics and add to sedation. [2] Tell the surgical team.
  • Allergy: skin reactions with itching, burning or hives have been reported with kava tea or supplements. [2]
  • Quality and contamination: NCCIH lists adulteration or contamination as a suggested contributor to liver cases. [1] The FDA memo says plant parts other than the root, other cultivars, or mould toxins may raise toxicity. [3] For label checks see quality testing and certifications.

Official statements

  • EMA (EU), HMPC public statement, 21 November 2017: the benefit-risk balance is unfavourable; the committee noted spontaneous reports of liver reactions including liver failure, liver transplants and deaths, and withdrawal of products in some Member States, and also toxicology concerns (carcinogenic potential in animals). An EU herbal monograph cannot be established. [4]
  • FDA (US), toxicology memorandum, 11 August 2020: the 2002 consumer advisory is described; the memo says kava is an unapproved food additive when used as an ingredient in conventional foods and that indiscriminate use as a relaxation drink is not safe. Kava supplements remain on sale in the US. [3]
  • Countries with restrictions: the FDA memo lists withdrawals or bans in France, Switzerland, the Czech Republic, Spain, the UK, Hungary, Portugal and Germany (up to 2015), and Canada since 2002. It reports that in Australia kava is a Schedule 4 medicine with a limit on kavalactones from water-based extracts. [3] MSK says Canadian, French and British governments withdrew kava products. [2] These rules change; the current legal status in your country: Proper evidence not found in the sources we read, so check with your national regulator.
  • NCCIH (US), page last updated April 2025: summary of the research and the liver warning above. [1]
  • MSK, page last updated 9 February 2022: the liver risk outweighs any benefits. [2]

Frequently asked questions

Is kava safe for the liver?

Not clearly. NCCIH reports rare but sometimes serious or fatal liver injury linked to kava products, including water-based drinks. [1] MSK says the liver risk outweighs any benefits. [2] Seek medical help quickly for yellow skin or eyes, nausea or vomiting. [2]

Is kava banned?

In several countries it has been withdrawn or banned, including France, Switzerland and Canada, according to an FDA memo. [3] In the US it is still sold as a supplement, though the FDA issued a liver warning in 2002. [3] Rules change, so check your own country's regulator.

Does kava work for anxiety?

Results are mixed. An older Cochrane review found a benefit over placebo, but a 2020 trial in people with diagnosed generalised anxiety disorder found none. [5][6] NCCIH says it does not appear to help generalised anxiety disorder. [1]

Can I drink alcohol or take sleeping pills or anxiety medicines with kava?

NCCIH advises against combining kava with alcohol or sedatives such as benzodiazepines. [1] MSK gives the same advice. [2]

Is kava safe in pregnancy?

NCCIH says kava may carry special risks in pregnancy and breastfeeding. [1] The sources we read do not show it to be safe, so ask a doctor or midwife first.

References
  1. National Center for Complementary and Integrative Health (NIH). Kava: Usefulness and Safety. Page last updated April 2025. Read 2026-10-23.
  2. Memorial Sloan Kettering Cancer Center. Kava: Purported Benefits, Side Effects & More. Page last updated 9 February 2022. Read 2026-10-23.
  3. US Food and Drug Administration, CFSAN/OFAS. Scientific memorandum: Review of the published literature pertaining to the safety of kava for use in conventional foods, 11 August 2020. Read 2026-10-23.
  4. European Medicines Agency, HMPC. Public statement on Piper methysticum G. Forst., rhizoma (EMA/HMPC/450588/2016), 21 November 2017. Read 2026-10-23.
  5. Kava extract for treating anxiety. Cochrane Database of Systematic Reviews, 2003. PubMed record PMID 12535473 (abstract read through Europe PMC). Read 2026-10-23.
  6. Kava for generalised anxiety disorder: a 16-week double-blind, randomised, placebo-controlled study. Australian and New Zealand Journal of Psychiatry, 2020. PubMed record PMID 31813230 (abstract read through Europe PMC). Read 2026-10-23.
  7. Liver transplantation and the use of KAVA: case report. 2019. PubMed record PMID 30668342 (abstract read through Europe PMC). Read 2026-10-23.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.